SL-279252 (PD1-Fc-OX40L)

PD-1-Fc-OX40L fusion protein · Shattuck Labs, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SL-279252 (PD1-Fc-OX40L), covering 2025-03-14 to 2025-03-14. Get the full timeline:

Most recent: Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]